CIMB Group Holdings Berhad:企業のM&A・事業提携・投資動向

◆英語タイトル:CIMB Group Holdings Berhad - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
◆商品コード:DATA904C1468
◆発行会社(調査会社):MarketLine
◆発行日:2018年7月
◆ページ数:73
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:マレーシア
◆産業分野:サービス
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD700 ⇒換算¥103,600見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD1,050 ⇒換算¥155,400見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

CIMB Group Holdings Berhad – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
Summary

Marketline’s CIMB Group Holdings Berhad Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by CIMB Group Holdings Berhad since January2007.

Synopsis

Marketline’s Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage.

Key Highlights

This report includes CIMB Group Holdings Berhad’s contact information and business summary, tables, graphs, a list of partners and targets, a breakdown of financial and legal advisors, deal types, top deals by deal value, detailed deal reports, and descriptions and contact details of the partner, target, investor, and vendor firms, where disclosed.

The profile also includes detailed deal reports for all M&A, private equity, public offering, venture financing, partnership and divestment transactions undertaken by CIMB Group Holdings Berhad. These deal reports contain information about target company financials, sources of financing, method of payment, deal values, and advisors for various parties, where disclosed.

Scope

- Provides intelligence on CIMB Group Holdings Berhad’s M&A, strategic partnerships and alliances, capital raising and private equity transactions.
- Detailed reports of various financial transactions undertaken by CIMB Group Holdings Berhad and its subsidiaries since 2007.
- Information about key financial and legal advisors for CIMB Group Holdings Berhad’s financial deals transactions.
- Financial deals tables and charts covering deal value and volumes trend, deal types and geography-based deal activity.

Reasons to buy

- Access comprehensive financial deals data along with charts and graph covering M&A, private equity, and partnerships and alliances.
- Form an independent opinion about CIMB Group Holdings Berhad’s growth strategies through the organic and inorganic activities undertaken since 2007.
- Track your competitors’ business structure and growth strategies.

【レポートの目次】

Table of Contents
COMPANY OVERVIEW AND KEY FACTS 2
TABLE OF CONTENTS 5
LIST OF TABLES 6
LIST OF FIGURES 6
TARGETS AND PARTNERS 7
MERGERS & ACQUISITIONS 8
Mergers and Acquisitions – Overview 8
Mergers and Acquisitions – Deal reports 9
CORPORATE VENTURING 39
Corporate Venturing – Deal reports 39
PARTNERSHIP 41
Partnership – Deal reports 41
CAPITAL RAISING 45
Capital Raising – Overview 45
Capital Raising – Deal reports 46
DIVESTMENTS 50
Divestments – Overview 50
Divestments – Deal reports 51
APPENDIX 63
Contact Us 63
About MarketLine Financial Deals Database 63
Deal Definition and Methodology 65
About MarketLine 72

List of Tables
Table 1: CIMB Group Holdings Berhad M&A volume and value trend (2014-YTD2018)
Table 2: CIMB Group Holdings Berhad M&A activity by geography (2014-YTD2018)
Table 3: CIMB Group Holdings Berhad capital raising volume and value trend (2014-YTD2018)
Table 4: CIMB Group Holdings Berhad capital raising by deal type (2014-YTD2018)
Table 5: CIMB Group Holdings Berhad divestments volume and value trend (2014-YTD2018)
Table 6: CIMB Group Holdings Berhad divestments activity by geography (2014-YTD2018)

List of Figures
Figure 1: CIMB Group Holdings Berhad M&A volume and value trend (2014-YTD2018)
Figure 2: CIMB Group Holdings Berhad M&A activity by geography (2014-YTD2018)
Figure 3: CIMB Group Holdings Berhad capital raising volume and value trend (2014-YTD2018)
Figure 4: CIMB Group Holdings Berhad capital raising by deal type (2014-YTD2018)
Figure 5: CIMB Group Holdings Berhad divestments volume and value trend (2014-YTD2018)
Figure 6: CIMB Group Holdings Berhad divestments by geography (2014-YTD2018)

★海外企業調査レポート[CIMB Group Holdings Berhad:企業のM&A・事業提携・投資動向]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Thor Mining Plc (THR):企業の財務・戦略的SWOT分析
    Summary Thor Mining Plc (Thor Mining) is a mining and mineral exploration and development company. The company carries out acquisition, exploration and develops gold, tungsten and molybdenum properties. Its projects include Molyhil Tungsten and Molybdenum, Spring Hill Gold, Dundas Gold project, and …
  • Evoke Pharma Inc (EVOK):製薬・医療:M&Aディール及び事業提携情報
    Summary Evoke Pharma Inc (Evoke Pharma) is a pharmaceutical company that develops drugs to treat gastrointestinal diseases. The company offers Gimoti that provides predictable absorption and symptom relief during a flare regardless of gastric emptying delays and vomiting. It also offers solutions fo …
  • EQT Corporation:企業の戦略・SWOT・財務分析
    EQT Corporation - Strategy, SWOT and Corporate Finance Report Summary EQT Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • ContraVir Pharmaceuticals Inc (CTRV):企業の財務・戦略的SWOT分析
    Summary ContraVir Pharmaceuticals Inc (ContraVir) is a biopharmaceutical company that offers development and commercialization of targeted antiviral therapies. The company provides pipeline product such as TXL, potent prodrug of antiviral tenofovir and CRV431 cyclophilin inhibitor that increases its …
  • Harte Hanks Inc (HHS):企業の財務・戦略的SWOT分析
    Harte Hanks Inc (HHS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • ImmusanT Inc-製薬・医療分野:企業M&A・提携分析
    Summary ImmusanT Inc (ImmusanT) is a drug company that discovers and develops therapies for celiac disease. The company’s pipeline products include Nexvax 2 and Nexvax 3. Its pipeline product Nexvax 2 is used for treating, preventing and diagnosing celiac disease. ImmusanT’s pipeline products are al …
  • Infor Global Solutions Inc:企業の戦略的SWOT分析
    Infor Global Solutions Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • ProterixBio Inc-医療機器分野:企業M&A・提携分析
    Summary ProterixBio Inc (ProterixBio), formerly BioScale Inc is a medical device company that manufactures and markets the ViBE platform products. The company offers ViBE platform, acoustic assays; ViBE software and custom assays. Its ViBE platform enables non-optical detection and sensitive quantit …
  • Otsuka Holdings Co Ltd (4578):医療機器:M&Aディール及び事業提携情報
    Summary Otsuka Holdings Co Ltd (Otsuka) is a holding company, which operates various businesses such as pharmaceuticals, nutraceuticals, consumer products and other businesses through its subsidiaries. It focuses on the research and development, manufacture, and sale of medicines for the treatment o …
  • Assembly Biosciences Inc (ASMB):企業の財務・戦略的SWOT分析
    Summary Assembly Biosciences Inc (Assembly), formerly Ventrus Biosciences Inc is a biotechnology company that develops, discovers, and commercializes small molecule therapies. The company develops therapies for the treatment of infectious diseases such as microbiotic therapies for Clostridium diffic …
  • Sunesis Pharmaceuticals Inc (SNSS):企業の財務・戦略的SWOT分析
    Sunesis Pharmaceuticals Inc (SNSS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • China Meheco Co Ltd:企業の戦略・SWOT・財務情報
    China Meheco Co Ltd - Strategy, SWOT and Corporate Finance Report Summary China Meheco Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Alabama Municipal Electric Authority:発電所・企業SWOT分析
    Alabama Municipal Electric Authority - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information …
  • Landis+Gyr AG:企業の戦略的SWOT分析
    Landis+Gyr AG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • STATS UK Ltd:企業の戦略的SWOT分析
    STATS UK Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • NxStage Medical Inc (NXTM):企業の財務・戦略的SWOT分析
    NxStage Medical Inc (NXTM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Baltimore Gas and Electric Company:電力:M&Aディール及び事業提携情報
    Summary Baltimore Gas and Electric Company (BGE), a subsidiary of Exelon Corporation, is a regulated public utility that purchases, transmits, distributes and sells electricity; and purchases, sells and distributes natural gas. The company also offers services such as billing, emergency response, me …
  • Promimic AB-医療機器分野:企業M&A・提携分析
    Summary Promimic AB (Promimic) is a biomaterial company that develops and markets implant surface modifications and synthetic bones. The company’s products comprise metals, ceramics, polymers, porous materials and pyrocarbon. Its HA-nano surface is a coating based on nanocrystalline hydroxyapatite p …
  • Bright Food (Group) Co Ltd:企業のM&A・事業提携・投資動向
    Bright Food (Group) Co Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Bright Food (Group) Co Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acqui …
  • Heron Resources Ltd:企業の戦略・SWOT・財務分析
    Heron Resources Ltd - Strategy, SWOT and Corporate Finance Report Summary Heron Resources Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆